Related Experiment Video
Updated: Jul 20, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Lessons Learned From Five Years of Newborn Screening for Severe Combined Immunodeficiency in Israel
Atar Lev1, Idan Sharir2, Amos J Simon3
1Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Mina and Everard Goodman Faculty of Life Sciences, Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat-Gan, Israel.
Insights
Newborn screening for severe combined immunodeficiency (SCID) in Israel diagnosed 32 infants, with a 91% survival rate after stem cell transplant. This program demonstrates the value of SCID screening for early detection and improved outcomes.
Area of Science:
- Immunology
- Genetics
- Public Health
Background:
- Newborn screening (NBS) for severe combined immunodeficiency (SCID) significantly improves infant outcomes.
- Long-term follow-up data from NBS programs are crucial for refining diagnostic and treatment strategies.
Purpose of the Study:
- To summarize a 5-year newborn screening program for SCID in Israel.
- To evaluate the immunologic, genetic, and clinical outcomes of infants identified through SCID screening.
Main Methods:
- Screened 937,953 Guthrie cards for SCID.
- Utilized flow cytometry, T cell receptor excision circle measurement, and TCRVβ repertoire analysis for validation.
- Collected and analyzed clinical and outcome data for diagnosed SCID cases.
Main Results:
- Identified an incidence of SCID at 1:29,000 births in Israel.
- Detected 32 SCID cases, with common genetic defects in DNA cross-link repair protein 1C and IL-7 receptor α genes.
- Achieved a 91% survival rate in 22 SCID patients who underwent hematopoietic stem cell transplantation.
Conclusions:
- Newborn screening for SCID is effective in early diagnosis and improving survival rates.
- Global implementation of SCID NBS, particularly in areas with high consanguinity, is recommended.
- Continued follow-up studies will enhance understanding of immune development and SCID management.
Background:
Implementation of newborn screening (NBS) programs for severe combined immunodeficiency (SCID) have advanced the diagnosis and management of affected infants and undoubtedly improved their outcomes. Reporting long-term follow-up of such programs is of great importance.
Objective:
We report a 5-year summary of the NBS program for SCID in Israel.
Methods:
Immunologic and genetic assessments, clinical analyses, and outcome data from all infants who screened positive were evaluated and summarized.
Results:
A total of 937,953 Guthrie cards were screened for SCID. A second Guthrie card was requested on 1,169 occasions (0.12%), which resulted in 142 referrals (0.015%) for further validation tests. Flow cytometry immune-phenotyping, T cell receptor excision circle measurement in peripheral blood, and expression of TCRVβ repertoire for the validation of positive cases revealed a specificity and sensitivity of 93.7% and 75.9%, respectively, in detecting true cases of SCID. Altogether, 32 SCID and 110 non-SCID newborns were diagnosed, making the incidence of SCID in Israel as high as 1:29,000 births. The most common genetic defects in this group were associated with mutations in DNA cross-link repair protein 1C and IL-7 receptor α (IL-7Rα) genes. No infant with SCID was missed during the study time. Twenty-two SCID patients underwent hematopoietic stem cell transplantation, which resulted in a 91% survival rate.
Conclusions:
Newborn screening for SCID should ultimately be applied globally, specifically to areas with high rates of consanguineous marriages. Accumulating data from follow-up studies on NBS for SCID will improve diagnosis and treatment and enrich our understanding of immune development in health and disease.
More Related Videos
14:14Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR
Published on: December 6, 2014
10:29Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling
Published on: April 3, 2026
Related Concept Videos
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...